INCB039110

Itacitinib · Incyte (as sponsor/associated entity)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INCB039110, covering 2023-09-22 to 2024-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD [Phase 2]